Equities

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Koninklijke Philips NV grew revenues 7.51% from 18.12bn to 19.48bn while net income improved 7.16% from 1.09bn to 1.17bn.
Gross margin44.44%
Net profit margin5.29%
Operating margin6.88%
Return on assets3.77%
Return on equity8.83%
Return on investment5.19%
More ▼

Cash flow in EURView more

In 2019, cash reserves at Koninklijke Philips NV fell by 263.00m. However, the company earned 2.01bn from its operations for a Cash Flow Margin of 10.30%. In addition the company used 603.00m on investing activities and also paid 1.67bn in financing cash flows.
Cash flow per share3.28
Price/Cash flow per share13.54
Book value per share14.01
Tangible book value per share-1.19
More ▼

Balance sheet in EURView more

Koninklijke Philips NV has a Debt to Total Capital ratio of 39.92%, unchanged from the previous year.
Current ratio1.33
Quick ratio0.9055
Total debt/total equity0.6662
Total debt/total capital0.3992
More ▼

Growth rates in EUR

Year on year, growth in dividends per share increased 4.69% while earnings per share excluding extraordinary items fell by -6.67%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is above the industry average.
Div yield(5 year avg)2.16%
Div growth rate (5 year)4.75%
Payout ratio (TTM)75.42%
EPS growth(5 years)39.74
EPS (TTM) vs
TTM 1 year ago
-28.25
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.